The landscape of the coronavirus disease 2019 (COVID-19) pandemic is rapidly changing, with new hot spots of concentrated coronavirus infections emerging across the US and around the world. Nearly every day, novel studies and insightful commentaries are being published by the JAMA Network and other leading biomedical journals. While the biology, epidemiology, prevention, diagnosis, and treatment of COVID-19 are the main focus of these reports, it will become increasingly important to study and address the health care needs of clinicians and other health care workers responding to the unprecedented demands of caring for patients with COVID-19.1,2
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
John Z. Ayanian, MD, MPP Dr John Ayanian is the inaugural Director of the Institute for Healthcare Policy and Innovation at the University of Michigan, the Alice Hamilton Distinguished University Professor of Medicine and Healthcare Policy, Professor of Health Management...